Literature DB >> 19342674

Lipocalin 2 is required for pulmonary host defense against Klebsiella infection.

Yvonne R Chan1, Jessica S Liu, Derek A Pociask, Mingquan Zheng, Timothy A Mietzner, Thorsten Berger, Tak W Mak, Matthew C Clifton, Roland K Strong, Prabir Ray, Jay K Kolls.   

Abstract

Antimicrobial proteins comprise a significant component of the acute innate immune response to infection. They are induced by pattern recognition receptors as well as by cytokines of the innate and adaptive immune pathways and play important roles in infection control and immunomodulatory homeostasis. Lipocalin 2 (siderocalin, NGAL, 24p3), a siderophore-binding antimicrobial protein, is critical for control of systemic infection with Escherichia coli; however, its role in mucosal immunity in the respiratory tract is unknown. In this study, we found that lipocalin 2 is rapidly and robustly induced by Klebsiella pneumoniae infection and is TLR4 dependent. IL-1beta and IL-17 also individually induce lipocalin 2. Mucosal administration of IL-1beta alone could reconstitute the lipocalin 2 deficiency in TLR4 knockout animals and rescue them from infection. Lipocalin 2-deficient animals have impaired lung bacterial clearance in this model and mucosal reconstitution of lipocalin 2 protein in these animals resulted in rescue of this phenotype. We conclude that lipocalin 2 is a crucial component of mucosal immune defense against pulmonary infection with K. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342674      PMCID: PMC2708928          DOI: 10.4049/jimmunol.0803282

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

1.  Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.

Authors:  Kyle I Happel; Mingquan Zheng; Erana Young; Lee J Quinton; Euan Lockhart; Alistair J Ramsay; Judd E Shellito; Jill R Schurr; Gregory J Bagby; Steve Nelson; Jay K Kolls
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

2.  Nosocomial lower respiratory tract infections: prevalence and risk factors in 14 Greek hospitals.

Authors:  D P Kofteridis; J A Papadakis; D Bouros; P Nikolaides; G Kioumis; S Levidiotou; E Maltezos; S Kastanakis; S Kartali; A Gikas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-12       Impact factor: 3.267

3.  Immunohistochemistry.

Authors:  Florence Hofman
Journal:  Curr Protoc Immunol       Date:  2002-08

4.  MyD88-dependent changes in the pulmonary transcriptome after infection with Chlamydia pneumoniae.

Authors:  Nuria Rodríguez; Jörg Mages; Harald Dietrich; Nina Wantia; Hermann Wagner; Roland Lang; Thomas Miethke
Journal:  Physiol Genomics       Date:  2007-03-20       Impact factor: 3.107

5.  Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase.

Authors:  L Kjeldsen; A H Johnsen; H Sengeløv; N Borregaard
Journal:  J Biol Chem       Date:  1993-05-15       Impact factor: 5.157

6.  Dexamethasone-induced expression of the glucocorticoid response gene lipocalin 2 in chondrocytes.

Authors:  H C Owen; S J Roberts; S F Ahmed; C Farquharson
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-04-01       Impact factor: 4.310

7.  Identification by microsequencing of lipopolysaccharide-induced proteins secreted by mouse macrophages.

Authors:  L A Meheus; L M Fransen; J G Raymackers; H A Blockx; J J Van Beeumen; S M Van Bun; A Van de Voorde
Journal:  J Immunol       Date:  1993-08-01       Impact factor: 5.422

8.  Neutrophil gelatinase-associated lipocalin is expressed in osteoarthritis and forms a complex with matrix metalloproteinase 9.

Authors:  Kalpana Gupta; Meenakshi Shukla; Jack B Cowland; Charles J Malemud; Tariq M Haqqi
Journal:  Arthritis Rheum       Date:  2007-10

9.  Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer.

Authors:  Frank J G M Kubben; Cornelis F M Sier; Lukas J A C Hawinkels; Harald Tschesche; Wim van Duijn; Kim Zuidwijk; Johan J van der Reijden; Roeland Hanemaaijer; Gerrit Griffioen; Cornelis B H W Lamers; Hein W Verspaget
Journal:  Eur J Cancer       Date:  2007-07-02       Impact factor: 9.162

10.  Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense.

Authors:  P Ye; F H Rodriguez; S Kanaly; K L Stocking; J Schurr; P Schwarzenberger; P Oliver; W Huang; P Zhang; J Zhang; J E Shellito; G J Bagby; S Nelson; K Charrier; J J Peschon; J K Kolls
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

View more
  104 in total

1.  Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection.

Authors:  Magnus Steigedal; Anne Marstad; Markus Haug; Jan K Damås; Roland K Strong; Pacita L Roberts; Stephanie D Himpsl; Ann Stapleton; Thomas M Hooton; Harry L T Mobley; Thomas R Hawn; Trude H Flo
Journal:  J Immunol       Date:  2014-11-14       Impact factor: 5.422

2.  The Role of NGAL in Peritoneal Dialysis Effluent in Early Diagnosis of Peritonitis: Case-Control Study in Peritoneal Dialysis Patients.

Authors:  Francesca Martino; Elisa Scalzotto; Davide Giavarina; Maria Pia Rodighiero; Carlo Crepaldi; Sonya Day; Claudio Ronco
Journal:  Perit Dial Int       Date:  2014-11-13       Impact factor: 1.756

3.  Roles of interleukin-17 in an experimental Legionella pneumophila pneumonia model.

Authors:  Yoshifumi Kimizuka; Soichiro Kimura; Tomoo Saga; Makoto Ishii; Naoki Hasegawa; Tomoko Betsuyaku; Yoichiro Iwakura; Kazuhiro Tateda; Keizo Yamaguchi
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

Review 4.  Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity.

Authors:  James E Cassat; Eric P Skaar
Journal:  Semin Immunopathol       Date:  2011-11-03       Impact factor: 9.623

5.  The v-myc-induced Q83 lipocalin is a siderocalin.

Authors:  Nicolas Coudevylle; Leonhard Geist; Matthias Hötzinger; Markus Hartl; Georg Kontaxis; Klaus Bister; Robert Konrat
Journal:  J Biol Chem       Date:  2010-09-08       Impact factor: 5.157

6.  Interleukin-1 receptor-associated kinase M-deficient mice demonstrate an improved host defense during Gram-negative pneumonia.

Authors:  Jacobien J Hoogerwerf; Gerritje J W van der Windt; Dana C Blok; Arie J Hoogendijk; Alex F De Vos; Cornelis van 't Veer; Sandrine Florquin; Koichi S Kobayashi; Richard A Flavell; Tom van der Poll
Journal:  Mol Med       Date:  2012-09-25       Impact factor: 6.354

Review 7.  Innate Immune Signaling Activated by MDR Bacteria in the Airway.

Authors:  Dane Parker; Danielle Ahn; Taylor Cohen; Alice Prince
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

8.  SPLUNC1/BPIFA1 contributes to pulmonary host defense against Klebsiella pneumoniae respiratory infection.

Authors:  Yang Liu; Jennifer A Bartlett; Marissa E Di; Jennifer M Bomberger; Yvonne R Chan; Lokesh Gakhar; Rama K Mallampalli; Paul B McCray; Y Peter Di
Journal:  Am J Pathol       Date:  2013-03-15       Impact factor: 4.307

9.  α-Intercalated cells defend the urinary system from bacterial infection.

Authors:  Neal Paragas; Ritwij Kulkarni; Max Werth; Kai M Schmidt-Ott; Catherine Forster; Rong Deng; Qingyin Zhang; Eugenia Singer; Alexander D Klose; Tian Huai Shen; Kevin P Francis; Sunetra Ray; Soundarapandian Vijayakumar; Samuel Seward; Mary E Bovino; Katherine Xu; Yared Takabe; Fábio E Amaral; Sumit Mohan; Rebecca Wax; Kaitlyn Corbin; Simone Sanna-Cherchi; Kiyoshi Mori; Lynne Johnson; Thomas Nickolas; Vivette D'Agati; Chyuan-Sheng Lin; Andong Qiu; Qais Al-Awqati; Adam J Ratner; Jonathan Barasch
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

10.  STAT6 Signaling Attenuates Interleukin-17-Producing γδ T Cells during Acute Klebsiella pneumoniae Infection.

Authors:  Melissa H Bloodworth; Dawn C Newcomb; Daniel E Dulek; Matthew T Stier; Jacqueline Y Cephus; Jian Zhang; Kasia Goleniewska; Jay K Kolls; R Stokes Peebles
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.